Quick Verdict

Tesamorelin drives stronger fat loss via GH receptor activation (FDA-approved for lipodystrophy). AOD-9604 offers targeted lipolysis without GH receptor binding — ideal for subjects who need fat loss without GH-axis concerns.

Side-by-Side Analysis

DimensionAOD-9604Tesamorelin
MechanismMimics GH fat-burning domain.Stimulates GH for fat metabolism.
Primary BenefitsFat loss without GH side effectsVisceral fat reduction, body recomposition
Typical Dose300–300mcg1000–1000mcg
RouteSubQSubQ
Frequency7x/wk7x/week
Half-Life1 hours0.43 hours
FDA StatusResearch OnlyApproved
Evidence Gradepreclinicalvery-strong
Key Studies18+ indexed20+ indexed
Lowest Price$49.99 / 5mg via Amino Club$69.99 / 10mg via Amino Club

Which one should you choose?

Tesamorelin produces substantially greater fat loss via powerful GH spikes; AOD-9604 offers a safer, gentler lipolytic effect without affecting blood sugar. Tesamorelin is FDA-approved for visceral fat and works by triggering massive GH release (activating the full GH receptor pathway). AOD-9604 is a GH fragment (177-191) that directly stimulates beta-3 adrenergic receptors in fat tissue — bypassing the growth receptor entirely. Choose Tesamorelin for aggressive visceral fat reduction. Choose AOD-9604 if you need fat loss without any GH-axis stimulation (e.g., active cancer concerns, blood sugar sensitivity).

Who Should Choose AOD-9604?

Choose AOD-9604 if you:

  • Want direct lipolysis without GH receptor stimulation
  • Are sensitive to blood sugar disruption from GH elevation
  • Are researching fat loss as an add-on to an existing GH protocol
  • Need a very mild, well-tolerated fat loss agent

Who Should Choose Tesamorelin?

Choose Tesamorelin if you:

  • Want the most aggressive visceral fat reduction available
  • Are comfortable with the full GHRH mechanism and GH stimulation
  • Are researching lipodystrophy or metabolic syndrome specifically
  • Want an FDA-approved mechanism with clinical trial data

Can you stack AOD-9604 + Tesamorelin?

These can be stacked carefully. AOD-9604 acts peripherally on fat cells; Tesamorelin acts centrally via the pituitary. The combination may produce additive fat loss effects. However, researchers should monitor IGF-1 and blood glucose when stacking any GH-axis peptide.

Vendor Pricing

· Affiliate links · Prices verified 2026

AOD-9604

2 vendors
Amino ClubEditor's Pick Best Value
5mg vial · $10.00/mg
$49.99Buy
Ascension Peptides
5mg vial · $12.00/mg
$59.99Buy

Tesamorelin

3 vendors
Amino ClubEditor's Pick Best Value
10mg vial · $7.00/mg
$69.99Buy
Ascension Peptides
5mg vial · $16.00/mg
$80.00Buy
Bio Longevity Labs
10mg vial · $9.00/mg
$89.98Buy

Affiliate disclosure: PeptiDex may earn a commission from purchases via vendor links at no extra cost to you. See our methodology.

Frequently Asked Questions

No — this is AOD-9604's key advantage. It does not bind the GH receptor and does not raise IGF-1 or affect blood sugar, unlike full-length GH or GHRH analogs like Tesamorelin.

Related Comparisons

Research Use Only — Not Medical Advice

This comparison is provided for educational and research purposes only. It does not constitute medical, prescribing, or treatment advice. Clinical data cited here is sourced from published peer-reviewed trials and FDA labels. Consult a qualified healthcare professional before making any decisions about medications or research compounds. PeptiDex is an informational resource and does not sell pharmaceutical products.